What if the next breakthrough in Alzheimer’s disease treatment came from the body’s own immune system?
In this short video interview with Wholesale Investor, Professor Alan Trounson AO, CEO and Executive Chair of Evinco Therapeutics, explains the science behind our novel NK cell-derived extracellular vesicle (NK-EV) platform and how it has the potential to transform the treatment of Alzheimer’s disease and other neuroinflammatory disorders. Discover why this innovative approach could open a new frontier in brain health and why Evinco is focused on translating this promising research into future therapies. Watch it here: https://www.youtube.com/watch?v=49eJIJbVQqY
